Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Non-Current Assets (2016 - 2025)

STRATA Skin Sciences' Other Non-Current Assets history spans 14 years, with the latest figure at $231000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $231000.0; the TTM value through Sep 2025 reached $231000.0, changed 0.0%, while the annual FY2024 figure was $231000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets for Q3 2025 was $231000.0 at STRATA Skin Sciences, roughly flat from $231000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $325000.0 in Q2 2024 and bottomed at $71000.0 in Q2 2023.
  • The 5-year median for Other Non-Current Assets is $231000.0 (2023), against an average of $198894.7.
  • The largest annual shift saw Other Non-Current Assets crashed 61.62% in 2023 before it soared 357.75% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $216000.0 in 2021, then plummeted by 54.63% to $98000.0 in 2022, then skyrocketed by 135.71% to $231000.0 in 2023, then changed by 0.0% to $231000.0 in 2024, then changed by 0.0% to $231000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Other Non-Current Assets are $231000.0 (Q3 2025), $231000.0 (Q2 2025), and $231000.0 (Q1 2025).